COVID-19 patients are more susceptible to inflammatory responses as they secrete excessive IL-6 cytokines and have a high chance of developing post-hepatectomy liver failure (PHLF) following hepatectomy [62,63]. The gene discussed is IL6; the disease is COVID-19.